FDA to review Vytorin results

The U.S. Food and Drug Administration said it is conducting a review of the cholesterol drug Vytorin based on preliminary results from a recent study.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news120576039.html">FDA to review Vytorin results</a></p> <p>The U.S. Food and Drug Administration said it is conducting a review of the cholesterol drug Vytorin based on preliminary results from a recent study.</p>